Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$2.8 - $7.67 $157,612 - $431,744
-56,290 Reduced 61.67%
34,981 $106,000
Q1 2022

May 16, 2022

SELL
$6.01 - $8.54 $421,631 - $599,123
-70,155 Reduced 43.46%
91,271 $620,000
Q4 2021

Feb 14, 2022

SELL
$7.11 - $9.64 $40,996 - $55,584
-5,766 Reduced 3.45%
161,426 $1.35 Million
Q3 2021

Nov 15, 2021

BUY
$5.04 - $8.73 $56,649 - $98,125
11,240 Added 7.21%
167,192 $1.24 Million
Q2 2021

Aug 16, 2021

BUY
$6.58 - $10.66 $50,383 - $81,623
7,657 Added 5.16%
155,952 $1.06 Million
Q1 2021

May 17, 2021

SELL
$6.73 - $13.87 $325,482 - $670,794
-48,363 Reduced 24.59%
148,295 $1.52 Million
Q4 2020

Feb 16, 2021

SELL
$6.37 - $10.33 $38,716 - $62,785
-6,078 Reduced 3.0%
196,658 $1.38 Million
Q3 2020

Nov 16, 2020

SELL
$4.58 - $10.95 $1.15 Million - $2.76 Million
-251,738 Reduced 55.39%
202,736 $1.65 Million
Q2 2020

Aug 17, 2020

SELL
$4.17 - $7.58 $700,647 - $1.27 Million
-168,021 Reduced 26.99%
454,474 $3.14 Million
Q1 2020

May 15, 2020

BUY
$2.91 - $8.7 $1.81 Million - $5.42 Million
622,495 New
622,495 $2.96 Million
Q3 2019

Nov 14, 2019

SELL
$3.33 - $4.93 $960,445 - $1.42 Million
-288,422 Closed
0 $0
Q2 2019

Aug 14, 2019

SELL
$4.3 - $6.73 $424,637 - $664,607
-98,753 Reduced 25.51%
288,422 $1.43 Million
Q1 2019

May 14, 2019

BUY
$3.43 - $6.87 $877,160 - $1.76 Million
255,732 Added 194.56%
387,175 $2.4 Million
Q4 2018

Feb 14, 2019

BUY
$2.69 - $6.71 $353,581 - $881,982
131,443 New
131,443 $443,000

Others Institutions Holding JNCE

About Jounce Therapeutics, Inc.


  • Ticker JNCE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 51,694,200
  • Description
  • Jounce Therapeutics, Inc., a clinical-stage immunotherapy company, develops therapies for the treatment of cancer. The company develops vopratelimab, a clinical-stage monoclonal antibody, which is in Phase II clinical trial that binds to and activates the Inducible T cell CO-Stimulator, a protein on the surface of T cells found in various solid ...
More about JNCE
Track This Portfolio

Track Aqr Capital Management LLC Portfolio

Follow Aqr Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.